Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Population Health Metrics
Published in: Population Health Metrics 1/2011

Open Access 01-12-2011 | Research

Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets

Authors: Richard Heijink, Pieter van Baal, Mark Oppe, Xander Koolman, Gert Westert

Published in: Population Health Metrics | Issue 1/2011

Login to get access

Abstract

Background

The validity, reliability and cross-country comparability of summary measures of population health (SMPH) have been persistently debated. In this debate, the measurement and valuation of nonfatal health outcomes have been defined as key issues. Our goal was to quantify and decompose international differences in health expectancy based on health-related quality of life (HRQoL). We focused on the impact of value set choice on cross-country variation.

Methods

We calculated Quality Adjusted Life Expectancy (QALE) at age 20 for 15 countries in which EQ-5D population surveys had been conducted. We applied the Sullivan approach to combine the EQ-5D based HRQoL data with life tables from the Human Mortality Database. Mean HRQoL by country-gender-age was estimated using a parametric model. We used nonparametric bootstrap techniques to compute confidence intervals. QALE was then compared across the six country-specific time trade-off value sets that were available. Finally, three counterfactual estimates were generated in order to assess the contribution of mortality, health states and health-state values to cross-country differences in QALE.

Results

QALE at age 20 ranged from 33 years in Armenia to almost 61 years in Japan, using the UK value set. The value sets of the other five countries generated different estimates, up to seven years higher. The relative impact of choosing a different value set differed across country-gender strata between 2% and 20%. In 50% of the country-gender strata the ranking changed by two or more positions across value sets. The decomposition demonstrated a varying impact of health states, health-state values, and mortality on QALE differences across countries.

Conclusions

The choice of the value set in SMPH may seriously affect cross-country comparisons of health expectancy, even across populations of similar levels of wealth and education. In our opinion, it is essential to get more insight into the drivers of differences in health-state values across populations. This will enhance the usefulness of health-expectancy measures.
Appendix
Available only for authorised users
Literature
1.
Mathers CD: Health expectancies: an overview and critical appraisal. In Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications. Edited by: Murray CJL Salomon JA Mathers CD Lopez AD. Geneva: WHO; 2002:177-204.
2.
Field MJ, Gold MR: Summarizing population health: directions for the development and application of population metrics. Washington DC: Institute Of Medicine; 1998.
3.
Murray CJ, Frenk J: A framework for assessing the performance of health systems. Volume 78. Bull World Health Organ; 2000:717-31.
4.
Mathers CD, Murray CJ, Ezzati M, Gakidou E, Salomon JA, Stein C: Population health metrics: crucial inputs to the development of evidence for health policy. Popul Health Metr 2003, 1: 6. 10.1186/1478-7954-1-6CrossRefPubMedPubMedCentral
5.
Murray CJ, Frenk J: Ranking 37th--measuring the performance of the U.S. health care system. N Engl J Med 2010, 362: 98-9. 10.1056/NEJMp0910064CrossRefPubMed
6.
Murray CJL, Salomon JA, Mathers CD: A critical examination of summary measures of population health. In Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications. Edited by: Murray CJL Salomon JA Mathers CD Lopez AD. Geneva: WHO; 2002:13-40.
7.
Mathers CD, Murray CJ, Salomon JA, Sadana R, Tandon A, Lopez AD, et al.: Healthy life expectancy: comparison of OECD countries in 2001. Aust N Z J Public Health 2003, 27: 5-11. 10.1111/j.1467-842X.2003.tb00372.xCrossRefPubMed
8.
Robine JM, Ritchie K: Healthy life expectancy: evaluation of global indicator of change in population health. BMJ 1991, 302: 457-60. 10.1136/bmj.302.6774.457CrossRefPubMedPubMedCentral
9.
Perenboom RJ, Van Herten LM, Boshuizen HC, Van Den Bos GA: Trends in disability-free life expectancy. Disabil Rehabil 2004, 26: 377-86. 10.1080/0963828032000174098CrossRefPubMed
10.
Murray CJ: Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994, 72: 429-45.PubMedPubMedCentral
11.
Murray CJ, Salomon JA, Mathers C: A critical examination of summary measures of population health. Bull World Health Organ 2000, 78: 981-94.PubMedPubMedCentral
12.
Mathers CD: Towards valid and comparable measurement of population health. Bull World Health Organ 2003, 81: 787-8.PubMed
13.
Dolan P: The measurement of Health-Related Quality of Life. In Handbook of Health Economics. Edited by: Culyer AJ, Newhouse JP. Amsterdam: Elsevier Science; 2000:1723-1760.
14.
Williams A: Calculating the global burden of disease: time for a strategic reappraisal? Health Econ 1999, 8: 1-8.CrossRefPubMed
15.
Williams A: Comments on the response by Murray and Lopez. Health Econ 2000, 9: 83-6. 10.1002/(SICI)1099-1050(200001)9:1<83::AID-HEC494>3.0.CO;2-VCrossRefPubMed
16.
Dolan P: Modeling valuations for EuroQol health states. Med Care 1997, 35: 1095-108. 10.1097/00005650-199711000-00002CrossRefPubMed
17.
Brazier J, Roberts J, Deverill M: The estimation of a preference based single index measure for health from the SF-36. Journal of Health Economics 2002, 21: 271-292. 10.1016/S0167-6296(01)00130-8CrossRefPubMed
18.
Feeny DH, Furling WJ, Torrance GW et al: Multiattribute and single attribute utility function - the health utility mark 3 system. Med Care 2002, 40: 113-128. 10.1097/00005650-200202000-00006CrossRefPubMed
19.
Muennig P, Franks P, Jia H, Lubetkin E, Gold MR: The income-associated burden of disease in the United States. Soc Sci Med 2005, 61: 2018-26. 10.1016/j.socscimed.2005.04.005CrossRefPubMed
20.
Wolfson MC: Health-Adjusted Life Expectancy. Statistics Canada: Health Reports 1996, 8: 41-46.PubMed
21.
Feeny D, Kaplan MS, Huguet N, McFarland BH: Comparing population health in the United States and Canada. Popul Health Metr 2010, 8: 8. 10.1186/1478-7954-8-8CrossRefPubMedPubMedCentral
22.
Murray CJL: Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study. Lancet 1997, 349: 1347-1352. 10.1016/S0140-6736(96)07494-6CrossRefPubMed
23.
Mathers CD, Sadana R, Salomon JA, Murray CJL, Lopez AD: Healthy life expectancy in 191 countries, 1999. Lancet 2001, 357: 1685-1691. 10.1016/S0140-6736(00)04824-8CrossRefPubMed
24.
Mathers CD, Lopez AD, Murray CJL: The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001. In Global Burden of Disease and Risk Factors. Edited by: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Washington DC: The International Bank for Reconstruction and Development/The World Bank; 2006.
25.
Salomon JA, Mathers CD, Chatterji S, Sadana R, Üstün B, Murray CJL: Quantifying Individual Levels of Health: Definitions, Concepts, and Measurement Issues. In Health Systems Performance Assessment: Debates, Methods and Empiricism. Edited by: Murray CJL, Evans DB. Geneva: World Health Organization; 2003.
26.
Üstün B, Rehm J, Chatterji S, Saxena S, Trotter R, Room R, Bickenbach J, the WHO/NIH Joint Project CAR Study Group: Multiple-informant ranking of disabling effect of different health conditions in 14 countries. Lancet 1999, 354: 111-115. 10.1016/S0140-6736(98)07507-2CrossRefPubMed
27.
Sommerfeld J, Baltussen RMPM, Metz L, Sanon M, Sauerborn R: Determinants of variance in health state valuations. In Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications. Edited by: Murray CJL Salomon JA Mathers CD Lopez AD. Geneva: WHO; 2002:549-580.
28.
29.
30.
Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33: 337-43. 10.3109/07853890109002087CrossRefPubMed
31.
Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM: Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005, 6: 124-30. 10.1007/s10198-004-0264-zCrossRefPubMed
32.
Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al.: Estimating an EQ-5D population value set: the case of Japan. Health Econ 2002, 11: 341-53. 10.1002/hec.673CrossRefPubMed
33.
Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ: [Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]. Ned Tijdschr Geneeskd 2005, 149: 1574-8.PubMed
34.
Badia X, Roset M, Herdman M, Kind P: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 2001, 21: 7-16. 10.1177/0272989X0102100102CrossRefPubMed
35.
Shaw JW, Johnson JA, Coons SJ: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005, 43: 203-20. 10.1097/00005650-200503000-00003CrossRefPubMed
36.
Torrance GW: Measurement of health state utilities for economic appraisal. J Health Econ 1986, 5: 1-30. 10.1016/0167-6296(86)90020-2CrossRefPubMed
37.
Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ: Valuations of EQ-5D health states: are the United States and United Kingdom different? Med Care 2005, 43: 221-8. 10.1097/00005650-200503000-00004CrossRefPubMed
38.
Parkin D, Rice N, Devlin N: Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference? Med Decis Making 2010, 30: 556-65. 10.1177/0272989X09357473CrossRefPubMed
39.
40.
Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ: Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care 2005, 43: 1078-86. 10.1097/01.mlr.0000182493.57090.c1CrossRefPubMed
41.
Robert SA, Cherepanov D, Palta M, Dunham NC, Feeny D, Fryback DG: Socioeconomic status and age variations in health-related quality of life: results from the national health measurement study. J Gerontol B Psychol Sci Soc Sci 2009, 64: 378-89.CrossRefPubMed
42.
Cherepanov D, Palta M, Fryback DG, Robert SA: Gender differences in health-related quality-of-life are partly explained by sociodemographic and socioeconomic variation between adult men and women in the US: evidence from four US nationally representative data sets. Qual Life Res 2010, 19: 1115-24. 10.1007/s11136-010-9673-xCrossRefPubMedPubMedCentral
43.
Pullenayegum EM, Tarride JE, Xie F, Goeree R, Gerstein HC, O'Reilly D: Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate? Value Health 2010, 13: 487-94. 10.1111/j.1524-4733.2010.00695.xCrossRefPubMed
44.
Preston SH, Ho J: Low Life Expectancy in the United States: Is the Health Care System at Fault?. Cambridge: National Bureau of Economic Research; 2009.CrossRef
45.
Wilper AP, Woolhandler S, Lasser KE, McCormick D, Bor DH, Himmelstein DU: Health insurance and mortality in US adults. Am J Public Health 2009, 99: 2289-95. 10.2105/AJPH.2008.157685CrossRefPubMedPubMedCentral
46.
Szende A, Oppe M, Devlin : EQ-5D value sets: inventory, comparative review and user guide. Dordrecht: Springer; 2007.CrossRef
47.
Salomon JA, Murray CJL, Üstün B, Chatterji S: Health State Valuations in Summary Measures of Population Health. In Health Systems Performance Assessment: Debates, Methods and Empiricism. Edited by: Murray CJL, Evans DB. Geneva: World Health Organization; 2003:409-436.
48.
Brazier J, Akehurst R, Brennan A, Dolan P, Claxton K, McCabe C, et al.: Should patients have a greater role in valuing health states? Appl Health Econ Health Policy 2005, 4: 201-8. 10.2165/00148365-200504040-00002CrossRefPubMed
49.
Brazier JE, Dixon S, Ratcliffe J: The role of patient preferences in cost-effectiveness analysis: a conflict of values? Pharmacoeconomics 2009, 27: 705-12. 10.2165/11314840-000000000-00000CrossRefPubMed
50.
McNamee P: What difference does it make? The calculation of QALY gains from health profiles using patient and general population values. Health Policy 2007, 84: 321-31. 10.1016/j.healthpol.2007.05.004CrossRefPubMed
51.
Drummond M, Brixner D, Gold M, Kind P, McGuire A, Nord E: Toward a consensus on the QALY. Value Health 2009,12(Suppl 1):s31-5.CrossRefPubMed
52.
De Wit GA, Busschbach JJ, De Charro FT: Sensitivity and perspective in the valuation of health status: whose values count? Health Econ 2000, 9: 109-26. 10.1002/(SICI)1099-1050(200003)9:2<109::AID-HEC503>3.0.CO;2-LCrossRefPubMed
53.
Dolan P, Kahneman D: Interpretations of utility and their implications for the valuation of health. The Economic Journal 2008, 118: 215-34.CrossRef
54.
Hanmer J, Hays RD, Fryback DG: Mode of Administration Is Important in US National Estimates of Health-Related Quality of Life. Medical Care 2007, 45: 1171-1179. 10.1097/MLR.0b013e3181354828CrossRefPubMed
55.
Sadana R, Mathers CD, Lopez AD, Murray CJL, Moesgaard Iburg K: Comparative analyses of more than 50 household surveys on health status. In Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications. Edited by: Murray CJ, Salomon JA, Mathers CD, Lopez AD. Geneva: WHO; 2002:369-386.
56.
Lindeboom M, Van Doorslaer E: Cut-Point Shift and Index Shift in Self-Reported Health. Bonn: Institute for the Study of Labor (IZA); 2004.
57.
Meijer E, Kapteyn A, Andreyeva T: Health Indexes and Retirement Modeling in International Comparisons. Santa Monica: RAND Labor and Population 2008.
58.
van Baal PH, Hoeymans N, Hoogenveen RT, de Wit GA, Westert GP: Disability weights for comorbidity and their influence on health-adjusted life expectancy. Popul Health Metr 2006, 4: 1. 10.1186/1478-7954-4-1CrossRefPubMedPubMedCentral
Metadata
Title
Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets
Authors
Richard Heijink
Pieter van Baal
Mark Oppe
Xander Koolman
Gert Westert
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Population Health Metrics / Issue 1/2011
Electronic ISSN: 1478-7954
DOI
https://doi.org/10.1186/1478-7954-9-17

Other articles of this Issue 1/2011

Population Health Metrics 1/2011 Go to the issue

Research

Falling behind: life expectancy in US counties from 2000 to 2007 in an international context

Research

Change in bias in self-reported body mass index in Australia between 1995 and 2008 and the evaluation of correction equations

Commentary

Computer-based analysis of verbal autopsies: revolution or evolution?

Research

Burden of type 2 diabetes attributed to lower educational levels in Sweden

Research

Validating physician-certified verbal autopsy and probabilistic modeling (InterVA) approaches to verbal autopsy interpretation using hospital causes of adult deaths

Editorial

Verbal autopsy: advancing science, facilitating application